Trial intelligence / Profile preview

Megestrol Acetate during Radiotherapy for Patients with Head and Neck Cancer

TCTR20240330005Phase 3Completed

Sponsor
Chiang Mai University
Start
May 2024
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of megestrol in head and neck cancer (HNC), sponsored by Chiang Mai University. Started May 2024; status: completed.

02

Drugs

megestrol
03

Conditions

head and neck cancer (HNC)

Beyond the preview

Go deeper on TCTR20240330005.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20240330005.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call